Abstract
The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference39 articles.
1. A Novel Coronavirus from Patients with Pneumonia in China, 2019
2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
3. A Call to Action: Philanthropy’s Commitment during COVID-19https://www.cof.org/news/call-action-philanthropys-commitment-during-covid-19
4. WHO, UN Foundation and Partners Launch First-of-its-kind COVID-19 Solidarity Response Fundhttps://www.who.int/news-room/detail/13-03-2020-who-un-foundation-and-partners-launch-first-of-its-kind-covid-19-solidarity-response-fund
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献